The 3,600 sqft facility will help develop the MIMIX sustained-release intradermal microneedle patch, which is planned for proof-of-concept trials for COVID-19 in 2022
As cleanroom standards evolve and technical demands increase, the Cleanroom Technology Conference offers a valuable snapshot of where the industry is heading.
Get breaking news, product releases, technical papers, innovation features, trend reports and live content agendas covering the entire industry.